Survival in Huntington’s disease and other young‐onset dementias
International Journal of Geriatric Psychiatry · 2023
DOI: 10.1002/gps.5913 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Geriatric Psychiatry, 2023. Verfasst von Samantha M Loi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Neuropsychiatry, NorthWestern Mental Health, Melbourne Health, Royal Melbourne Hospital, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Huntington Disease, Frontotemporal Dementia, Alzheimer Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Objectives
To compare survival and risk factors associated with mortality in common young‐onset dementias (YOD) including Huntington's disease.
Methods
This retrospective cohort study included inpatients from an Australian specialist neuropsychiatry service, over 20 years. Dementia diagnoses were based on consensus criteria and Huntington's disease (HD) was confirmed genetically. Mortality and cause of death were determined using linkage to the Australian Institute of Health and Welfare National Death Index.
Results
There were 386 individuals with YOD included. The dementia types included frontotemporal dementia (FTD) (24.5%), HD (21.2%) and Alzheimer's disease (AD) (20.5%). 63% ( n = 243) individuals had died. The longest median survival was for those who had HD, 18.8 years from symptom onset and with a reduced mortality risk compared to AD and FTD (hazard ratio 0.5). Overall, people with YOD had significantly increased mortality, of 5–8 times, compared to the general population. Females with a YOD had higher standardised mortality ratio compared to males (9.3 vs. 4.9) overall. The most frequent cause of death in those with HD was reported as HD, with other causes of death in the other YOD‐subtypes related to dementia and mental/behavioural disorders.
Discussion
This is the first Australian study to investigate survival and risk factors of mortality in people with YOD. YOD has a significant risk of death compared to the general population. Our findings provide useful clinical information for people affected by YOD as well as future planning and service provision.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuropsychiatry, NorthWestern Mental Health, Melbourne Health, Royal Melbourne Hospital, Parkville, Victoria, Australia.
- Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia.
- Department of Neurology, Evaggelismos Hospital, Athens, Greece.
- School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia.
- Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
- Department of Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia.
ORCID-Profile: Samantha M Loi
Förderung
- National Health and Medical Research Council
Zitieren
APA
Loi, S. M., Tsoukra, P., Sun, E., Chen, Z., Wibawa, P., Biase, M. D., Farrand, S., Eratne, D., Kelso, W., Evans, A., Walterfang, M., & Velakoulis, D. (2023). Survival in Huntington’s disease and other young‐onset dementias. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.5913
Vancouver
Loi SM, Tsoukra P, Sun E, Chen Z, Wibawa P, Biase MD, et al. Survival in Huntington’s disease and other young‐onset dementias. International Journal of Geriatric Psychiatry. 2023. doi:10.1002/gps.5913
BibTeX
@article{Loi2023,
author = {Loi, Samantha M and Tsoukra, Paraskevi and Sun, Emily and Chen, Zhibin and Wibawa, Pierre and Biase, Maria di and Farrand, Sarah and Eratne, Dhamidhu and Kelso, Wendy and Evans, Andrew and Walterfang, Mark and Velakoulis, Dennis},
title = {Survival in Huntington’s disease and other young‐onset dementias},
journal = {International Journal of Geriatric Psychiatry},
year = {2023},
doi = {10.1002/gps.5913}
}
EUVIMED